Project
All work
Ikarovec
Sector
Ophthalmology
Gene Therapy
Stage
Start-up & Scale-up
Location
Oxford, UK
Year
2026
Services
Web Design
Pitch Decks
Design Retainer
View website
Overview
Dual-Pathway Gene Therapy for Retinal Disease
Ikarovec is a gene therapy company developing dual-pathway treatments for chronic retinal diseases, including geographic atrophy and retinitis pigmentosa. Their platform utilises unique vector design to bring meaningful vision-preserving therapies to patients. We were tasked with helping Ikarovec capture the capabilities and workings of this complex platform and their lead assets through impactful graphic design for investor communications and partnering.
The challenge
Ikarovec needed to explain a complex dual-pathway platform, and its lead asset IKAR-001, clearly enough to stand out with investors and partners.
Our approach
We built a visual identity shaped by detailed scientific infographics and bespoke 3D assets that break the mechanism down in a visually intuitive way.
01
Web Design
A science-focused website for a complex platform
Ikarovec approached us to create a modern, science-focused website that could clearly communicate their complex platform and differentiate their approach. We built a cohesive visual identity shaped by detailed scientific infographics and bespoke 3D assets that break down Ikarovec’s dual-pathway mechanism in a visually intuitive way. The hero section sets the tone with a clean, ophthalmology-focused visual, while deeper pages—like Technology and Therapeutic Areas— use 3D graphics to show how neuroprotection and complement modulation work together within their lead asset, IKAR-001.


02
Pitch Decks
A corporate deck in the same visual language
We designed Ikarovec’s corporate deck, carrying the same visual language across both digital and presentation formats to create a cohesive and confident brand presence.
03
Design Retainer
A website that grows with the company
As Ikarovec continues to grow, the website has evolved under our retainer, including the recent addition of a dedicated Investors page.

Outcome
A cohesive and confident brand presence
The website and deck now share one visual language, giving Ikarovec a consistent presence across digital and presentation formats. In October 2024 Ikarovec reached an £8M seed round.

“
We would highly recommend Reciprocal Space to any life science company looking for a creative and reliable partner. They listened carefully to our brief and truly understood our vision, delivering a website and deck that feel both exciting and fresh.
Dr Katie Binley
Chief Strategy Officer



